Literature DB >> 17213364

Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis.

Phillip H Kuo, Emanuel Kanal, Ali K Abu-Alfa, Shawn E Cowper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17213364     DOI： 10.1148/radiol.2423061640

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  158 in total

1.  Albumin-based nanoparticles as magnetic resonance contrast agents: II. Physicochemical characterisation of purified and standardised nanoparticles.

Authors:  A A Abdelmoez; G C Thurner; E A Wallnöfer; N Klammsteiner; C Kremser; H Talasz; M Mrakovcic; E Fröhlich; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2010-07-14       Impact factor: 4.304

2.  Time spatial labeling inversion pulse cerebral MR angiography without subtraction by use of dual inversion recovery background suppression.

Authors:  Yoshiyuki Ishimori; Masahiko Monma; Hiraku Kawamura; Tomoko Miyata
Journal:  Radiol Phys Technol       Date:  2010-12-01

3.  Off-label use of intravascular iodinated organic and MR contrast media.

Authors:  O Tamburrini; I Aprile; C Falcone; D Console; A Rotundo; A Rotondo
Journal:  Radiol Med       Date:  2010-10-27       Impact factor: 3.469

4.  ACCF/AHA 2007 Clinical Competence Statement on vascular imaging with computed tomography and magnetic resonance.

Authors:  Christopher M Kramer; Matthew J Budoff; Zahi A Fayad; Victor A Ferrari; Corey Goldman; John R Lesser; Edward T Martin; Sanjay Rajagopalan; John P Reilly; George P Rodgers; Lawrence Wechsler
Journal:  Vasc Med       Date:  2007-11       Impact factor: 3.239

5.  Advances in Magnetic Resonance Imaging for the assessment of degenerative disc disease of the lumbar spine.

Authors:  Chenyang Wang; Joshua D Auerbach; Walter R T Witschey; Richard A Balderston; Ravinder Reddy; Arijit Borthakur
Journal:  Semin Spine Surg       Date:  2007-06

6.  A nephrotoxicity-free, iron-based contrast agent for magnetic resonance imaging of tumors.

Authors:  Xiangdong Xue; Ruonan Bo; Haijing Qu; Bei Jia; Wenwu Xiao; Ye Yuan; Natalia Vapniarsky; Aaron Lindstrom; Hao Wu; Dalin Zhang; Longmeng Li; Marina Ricci; Zhao Ma; Zheng Zhu; Tzu-Yin Lin; Angelique Y Louie; Yuanpei Li
Journal:  Biomaterials       Date:  2020-07-15       Impact factor: 12.479

7.  Biodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents.

Authors:  Ching-Hui Huang; Kido Nwe; Ajlan Al Zaki; Martin W Brechbiel; Andrew Tsourkas
Journal:  ACS Nano       Date:  2012-10-29       Impact factor: 15.881

8.  Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium-based contrast agents.

Authors:  Emmanuil Smorodinsky; David S Ansdell; Zeke W Foster; Sameer M Mazhar; Irene Cruite; Tanya Wolfson; Sebastian B Sugay; Gabriella Iussich; Masoud Shiehmorteza; Yuko Kono; Alexander Kuo; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2014-05-09       Impact factor: 4.813

Review 9.  Imaging of liver cancer.

Authors:  Ben Ariff; Claire R Lloyd; Sameer Khan; Mohamed Shariff; Andrew V Thillainayagam; Devinder S Bansi; Shahid A Khan; Simon D Taylor-Robinson; Adrian K P Lim
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

10.  Detection of Sulfatase Enzyme Activity with a CatalyCEST MRI Contrast Agent.

Authors:  Sanhita Sinharay; Gabriela Fernández-Cuervo; Jasmine P Acfalle; Mark D Pagel
Journal:  Chemistry       Date:  2016-03-23       Impact factor: 5.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.